At Vienna's Medical University, researchers are mapping the hidden choreography of metabolic change that unfolds inside the body after bariatric surgery — and what they're finding reshapes how doctors should think about these procedures. A novel PET imaging framework, presented at the 2026 Society of Nuclear Medicine and Molecular Imaging Annual Meeting, reveals that weight loss tells only part of the story. The surgery triggers a coordinated metabolic symphony across dozens of organs, from fat tissue to the liver, pancreas, and immune system.
The stakes matter enormously. Tens of thousands of Americans choose bariatric surgery each year, seeking durable weight loss and freedom from lifelong medication. For these patients, the first year after surgery is critical—a window where proper monitoring can mean the difference between successful recovery and hidden complications. Yet until now, clinicians have lacked a clear window into what's actually happening metabolically during this crucial period.
Zeyang Wang, a Ph.D. candidate in Nuclear Medicine at Medical University of Vienna, led a retrospective study of 32 patients with obesity who underwent either laparoscopic sleeve gastrectomy or one-anastomosis gastric bypass. All participants received whole-body 18F-FDG PET/CT scans—advanced imaging that tracks metabolic activity—both before surgery and one year afterward. The team measured 18F-FDG uptake across subcutaneous and visceral adipose tissue, liver, pancreas, spleen, adrenal glands, and skeletal muscle, then compared results with healthy controls.
What emerged was striking. Surgery didn't simply shrink fat; it orchestrated metabolic changes across fat, liver, pancreas, muscle, cardiovascular structures, bone-related tissues, and immune-endocrine organs. Changes in organ metabolism and volume correlated directly with improvements in glycemic control, lipid profiles, hormone levels, and inflammatory markers—the physiological hallmarks of recovery. Network analysis revealed something equally important: the connections between organs strengthened after surgery, indicating that metabolic processes across the entire body became more synchronized.
In one striking example visible in the imaging, a 20-year-old woman showed reductions in subcutaneous and visceral adipose tissue, liver volume, pancreas, spleen, and skeletal muscle after 12 months, with apparent enlargement of the colon—a sign of the body's structural remodeling. This multi-organ remodeling, captured in vivid detail by PET/CT, cannot be detected by weight scales or standard blood work alone.
"Molecular imaging may help show how different organs respond after surgery, beyond what can be measured by weight loss or blood tests alone," Wang said. The implications are profound. Rather than viewing bariatric surgery as simply a weight-loss intervention, clinicians can now understand it as a whole-body metabolic reset that requires personalized monitoring of organ-level responses.
This work supports the integration of whole-body PET/CT as a clinical tool for mapping organ-level metabolic health during the critical recovery year. For patients navigating post-surgery life, these findings suggest that metabolic recovery is far more coordinated and complex than previously understood—a reminder that the body's wisdom often exceeds what our older diagnostic tools can measure.